ECONOMIC EVALUATION OF VILDAGLIPTIN COMPARED TO GLIMEPIRIDE AS ADD-ON TO METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 PATIENTS IN GREECE

被引：2
|
作者：
Hatzikou, M. [1 ]
Rombopoulos, G. [1 ]
Yfantopoulos, J. [2 ]
机构：
[1] Novartis Hellas, Metamorfosis, Greece
[2] Univ Athens, Athens 11528, Greece
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1686
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [21] Effect of empagliflozin compared with glimepiride as add-on to metformin for 2 years on the amount and distribution of body fat in patients with type 2 diabetes
    Kim, G.
    Ridderstrale, M.
    Andersen, K. R.
    Zeller, C.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2014, 57 : S330 - S331
  • [22] Treatment adherence with vildagliptin compared to sulphonylurea as add- on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan
    Hanif, W.
    Malik, W.
    Hassanein, M.
    Kamal, A.
    Geransar, P.
    Andrews, C.
    Azam, M.
    Barnett, A. H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (07) : 807 - 811
  • [23] Vildagliptin versus insulin as add-on therapy to glimepiride in type 2 diabetes mellitus: results from a randomised controlled trial
    Strotmann, H. -J.
    Goetze, D.
    Koch, C.
    Forst, T.
    DIABETOLOGIA, 2014, 57 : S364 - S365
  • [24] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    DIABETES, 2016, 65 : A293 - A293
  • [25] Effectiveness of vildagliptin as add-on to metformin monotherapy among uncontrolled type 2 diabetes mellitus patients in a real-world setting
    Melzer Cohen, Cheli
    Davis, Carla
    Shalev, Varda
    Chodick, Gabriel
    JOURNAL OF DIABETES, 2018, 10 (01) : 68 - 72
  • [26] COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN FOR THE TREATMENT OF TYPE 2 DIABETES IN GREECE
    Tzanetakos, C.
    Tentolouris, N.
    Kourlaba, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A607
  • [27] Linagliptin versus glimepiride add-on for the long-term treatment of Type 2 diabetes mellitus
    Chilton, Robert
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (04) : 345 - 349
  • [28] Efficacy and Safety of Gemigliptin as Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on Metformin and Glimepiride
    Han, Kyung Ah
    Yu, Jae Myung
    Jang, Hak Chul
    Ahn, Kyu Jeung
    Oh, Takkeun
    Lee, Hyoung Woo
    Lee, Daeho
    Kim, Jae Taek
    Park, Tae Sun
    Nam, Joo Young
    Chung, Choon Hee
    Kim, Byung-Joon
    Park, Seok Won
    Kim, Sung-Ho
    Park, Kyong Soo
    DIABETES, 2016, 65 : A307 - A307
  • [29] Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride
    Kim, S. -H.
    Yu, J.
    Jang, H.
    Song, Y.
    Ahn, K.
    Oh, T.
    Lee, H.
    Lee, D.
    Kim, J.
    Park, T. -S.
    Jeong, C. -H.
    Kim, B. -J.
    Han, K.
    Park, K.
    DIABETOLOGIA, 2016, 59 : S357 - S357
  • [30] Empagliflozin as add-on to metformin in patients with Type 2 diabetes
    Merker, L.
    Haering, H. U.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Meinicke, T.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 89 - 89
12345